Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Bækvad-Hansen, M. Dahl, A. Tybjærg-Hansen, B.G. Nordestgaard (Copenhagen, Denmark). Oral presentation: Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function and COPD in smokers. Lung Science Conference 2010 - Biology of gene-environment interactions in the lung

Member's Comments

No comment yet.

Related content which might interest you: Surfactant protein-B polymorphisms, pulmonary function and COPD in 10,231 individuals Source: Annual Congress 2010 - Genetics and risk factors for asthma and COPD Year: 2010 Interstitial lung disease in a child heterozygous for the 1549C?GAA (121ins2) mutation of surfactant protein B Source: Eur Respir J 2011; 38: 985-987 Year: 2011 Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Heterozygosity for E292V in ABCA3, lung function and COPD in 64,000 individuals Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012 Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals Source: Eur Respir J 2011; 37: 791-799 Year: 2011 Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 Plasma surfactant protein-D (SPD) concentration and severity of airflow limitation in COPD patients (pts) Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Serum levels of surfactant proteins in patients with combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2015 – IPF pathogenesis Year: 2015 Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene Source: Eur Respir J 2004; 24: 30-39 Year: 2004 Association between the human surfactant protein-A (SP-A) gene locus and chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 583s Year: 2006 Polymorphic variation in surfactant protein B is associated with COPD exacerbations Source: Eur Respir J 2008; 32: 938-944 Year: 2008 MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Plasma surfactant protein D (SP-D) and smoking status in patients with COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Surfactant protein A (SP-A) and alveolar complement activation in patients at-risk for ARDS Source: Eur Respir J 2002; 20: Suppl. 38, 375s Year: 2002 The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Association of pulmonary alveolar proteinosis and fibrosis: patient with GATA2 deficiency Source: Eur Respir J 2016; 48: 1510-1514 Year: 2016 SP-C deficiency: Three different phenotypes for the same mutation Source: International Congress 2015 – Paediatric bronchology Year: 2015 Ataluren in nonsense mutation cystic fibrosis patients not receiving chronic inhaled tobramycin: Evaluation of exacerbations and lung function Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias Source: Eur Respir J 2007; 29: 134-137 Year: 2007